ImClone/Bristol Aim To Expand Erbitux’s Reach To Asia
This article was originally published in The Pink Sheet Daily
Executive Summary
Development partners broker deal with Merck KGaA to bring the first EGFR receptor-inhibiting monoclonal antibody to Japan.